Mapp Biopharmaceutical, a US-based company, developed ZMapp as a treatment for Ebola virus disease. The drug gained attention during the 2014-2016 Ebola outbreak in West Africa. Other companies listed (Pfizer, Novartis, Astra Zeneca, GlaxoSmithKline) are major pharmaceutical companies but not associated with ZMapp.